{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:58:15Z","timestamp":1790312295482,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"COEN (Centres of Excellence in Neurodegeneration)"},{"name":"Italian Ministry of Health"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.nbd.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T04:00:18Z","timestamp":1434686418000},"page":"235-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells"],"prefix":"10.1016","volume":"82","author":[{"given":"Giulia","family":"Ambrosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zangaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Levandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Blandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.06.008_bb0005","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2015.06.008_bb0010","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.bbadis.2014.05.008","article-title":"Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease","volume":"1842","author":"Ambrosi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2015.06.008_bb0015","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.neurobiolaging.2010.01.004","article-title":"Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease","volume":"32","author":"Armentero","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.nbd.2015.06.008_bb0020","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.parkreldis.2014.09.003","article-title":"Glucocerebrosidase mutations in primary parkinsonism","volume":"20","author":"Asselta","year":"2014","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nbd.2015.06.008_bb0025","doi-asserted-by":"crossref","first-page":"e25179","DOI":"10.4161\/cib.25179","article-title":"GSK-3 and lysosomes meet in Alzheimer's disease","volume":"6","author":"Avrahami","year":"2013","journal-title":"Commun. Integr. Biol."},{"issue":"47","key":"10.1016\/j.nbd.2015.06.008_bb0030","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1038\/emm.2014.128","article-title":"Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and \u03b1-synuclein aggregation","volume":"27","author":"Bae","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.nbd.2015.06.008_bb0035","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/humu.22124","article-title":"Gaucher disease paradigm: from ERAD to comorbidity","volume":"33","author":"Bendikov-Bar","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2015.06.008_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","article-title":"Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase","volume":"50","author":"Bendikov-Bar","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.nbd.2015.06.008_bb0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1750-1172-9-86","article-title":"Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS","volume":"9","author":"Bendikov-Bar","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nbd.2015.06.008_bb0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.wnl.0000198511.09968.b3","article-title":"Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease","volume":"66","author":"Blandini","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.06.008_bb0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/cdd.2010.142","article-title":"Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress","volume":"18","author":"Bouman","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2015.06.008_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbadis.2013.01.004","article-title":"Enhanced parkin levels favor ER-mitochondria crosstalk and guarantee Ca(2+) transfer to sustain cell bioenergetics","volume":"1832","author":"Cal\u00ec","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.nbd.2015.06.008_bb0065","doi-asserted-by":"crossref","first-page":"e37467","DOI":"10.1371\/journal.pone.0037467","article-title":"Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts","volume":"7","author":"Cartelli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.06.008_bb0075","doi-asserted-by":"crossref","first-page":"ra10","DOI":"10.1126\/scisignal.2001731","article-title":"ER stress inhibits mTORC2 and Akt signaling through GSK-3\u03b2-mediated phosphorylation of rictor","volume":"4","author":"Chen","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.nbd.2015.06.008_bb0080","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/jnc.12497","article-title":"Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells","volume":"128","author":"Crabtree","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.06.008_bb0085","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1038\/cddis.2013.222","article-title":"ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3\u03b2 in the signal network","volume":"4","author":"Feng","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2015.06.008_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","article-title":"Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: implications for Parkinson's disease","volume":"97","author":"Golpich","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2015.06.008_bb0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0950-3536(97)80032-7","article-title":"Gaucher's disease: molecular, genetic and enzymological aspects","volume":"10","author":"Grabowski","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.nbd.2015.06.008_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abbi.1997.9958","article-title":"Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside","volume":"341","author":"Hiraiwa","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.nbd.2015.06.008_bb0105","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.06.008_bb0110","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1042\/BST20130158","article-title":"Emerging insights into the mechanistic link between \u03b1-synuclein and glucocerebrosidase in Parkinson's disease","volume":"41","author":"McGlinchey","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2015.06.008_bb0115","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.06.008_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/187152409788452045","article-title":"Biochemistry and neurobiology of prosaposin: a potential therapeutic neuro-effector","volume":"9","author":"Misasi","year":"2009","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.nbd.2015.06.008_bb0125","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/brain\/awt224","article-title":"Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease","volume":"136","author":"Mortiboys","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.06.008_bb0130","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1093\/hmg\/ddu299","article-title":"Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins","volume":"23","author":"Motta","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.06.008_bb0135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased \u03b1-synuclein in sporadic Parkinson's disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.06.008_bb0140","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2015.06.008_bb0145","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.neurobiolaging.2013.01.008","article-title":"Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation","volume":"34","author":"Nijholt","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2015.06.008_bb0150","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.parkreldis.2009.03.002","article-title":"A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P+A53T transgenic mice","volume":"15","author":"Ono","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2015.06.008_bb0155","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.06.008_bb0160","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/MCB.00930-12","article-title":"Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-\u03b2 precursor protein","volume":"32","author":"Parr","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2015.06.008_bb0165","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.06.008_bb0170","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s13311-014-0294-x","article-title":"A GCase chaperone improves motor function in a mouse model of synucleinopathy","volume":"11","author":"Richter","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2015.06.008_bb0175","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease","volume":"19","author":"Ron","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"43","key":"10.1016\/j.nbd.2015.06.008_bb0180","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","article-title":"LIMP-2 expression is critical for \u03b2-glucocerebrosidase activity and \u03b1-synuclein clearance","volume":"111","author":"Rothaug","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.06.008_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pneurobio.2014.12.001","article-title":"Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle","volume":"125C","author":"Sardi","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2015.06.008_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","article-title":"Glucocerebrosidase and Parkinson disease: recent advances","volume":"66(Pt A)","author":"Schapira","year":"2015","journal-title":"Mol Cell Neurosci."},{"key":"10.1016\/j.nbd.2015.06.008_bb0195","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.1300822110","article-title":"Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease","volume":"110","author":"Schapira","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.06.008_bb0200","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.nbd.2015.06.008_bb0205","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1379\/CSC-281.1","article-title":"ER stress induces alternative nonproteasomal degradation of ER proteins but not of cytosolic ones","volume":"12","author":"Shenkman","year":"2007","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.nbd.2015.06.008_bb0210","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2015.06.008_bb0215","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2015.06.008_bb0220","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocerebrosidase is shaking up the synucleinopathies","volume":"137","author":"Siebert","year":"2014","journal-title":"Brain"},{"issue":"Pt 1","key":"10.1016\/j.nbd.2015.06.008_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj2960015","article-title":"Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling","volume":"296","author":"Sutherland","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2015.06.008_bb0230","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2015.06.008_bb0235","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.chembiol.2014.06.008","article-title":"ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease","volume":"21","author":"Tan","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.nbd.2015.06.008_bb0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4161\/auto.7.1.13884","article-title":"Autophagy in Gaucher disease due to saposin C deficiency","volume":"7","author":"Tatti","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2015.06.008_bb0240","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1093\/hmg\/dds367","article-title":"Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts","volume":"21","author":"Tatti","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.06.008_bb0250","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.06.008_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and parkinsonism","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2015.06.008_bb0260","first-page":"269","article-title":"Regulation and functions of the glycogen synthase kinase-3 subfamily","volume":"5","author":"Woodgett","year":"1994","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.nbd.2015.06.008_bb0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mcn.2015.01.003","article-title":"Chaperone mediated autophagy to the rescue: a new-fangled target for the treatment of neurodegenerative diseases","volume":"66(Pt A)","author":"Xilouri","year":"2015","journal-title":"Mol Cell Neurosci."},{"key":"10.1016\/j.nbd.2015.06.008_bb0270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1073\/pnas.1321341111","article-title":"Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.06.008_bb0275","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1021\/bi401191v","article-title":"Saposin C protects glucocerebrosidase against \u03b1-synuclein inhibition","volume":"52","author":"Yap","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2015.06.008_bb0280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature07203","article-title":"From endoplasmic-reticulum stress to the inflammatory response","volume":"454","author":"Zhang","year":"2008","journal-title":"Nature"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115002260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115002260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T19:49:28Z","timestamp":1540583368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115002260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":55,"alternative-id":["S0969996115002260"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.06.008","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}